Effects of anti-allergic drugs on human neutrophil superoxide-generating NADPH oxidase

Biochemical Pharmacology

Volumn 43, Issue 5, 1992, Pages 1109-1117

  Umeki, Shigenobu ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIALLERGIC AGENT; AZELASTINE; HISTAMINE H1 RECEPTOR; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROCORTISONE; IBUDILAST; KETOTIFEN; OXATOMIDE; OXYGEN RADICAL; PHORBOL 13 ACETATE 12 MYRISTATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REPIRINAST; SUPEROXIDE; SUPEROXIDE DISMUTASE; TRANILAST;

ARTICLE; CELL FREE SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NEUTROPHIL; PRIORITY JOURNAL;

ANTHRANILIC ACIDS; CELL-FREE SYSTEM; COMPARATIVE STUDY; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE H1 ANTAGONISTS; HUMAN; IMMUNOSUPPRESSIVE AGENTS; KETOTIFEN; KINETICS; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; NEUTROPHILS; PHTHALAZINES; PIPERAZINES; PYRIDINES; QUINOLONES; STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T;

EID: 0026503250     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(92)90619-T     Document Type: Article

References (46)

1. Phagocytosis
2. The biochemical basis of phagocytosis. I. Metabolic changes during the ingestion of particles by polymorphonuclear leukocytes
3. The production by leukocytes of Superoxide, a potential bactericidal agent
4. Mechanism of phagocytosis-associated oxidative metabolism in polymorphonuclear leukocytes and macrophages
5. The influence of phorbol myristate acetate on oxygen consumption by polymorphonuclear leukocytes
6. Oxygen-dependent microbial killing by phagocytes
7. Inhibition of Superoxide anion production in non-stimulated guinea pig peritoneal exudate cells by anti-inflammatory drugs
8. The different inhibitory effects of phenylbutazone on soluble and particle stimulation of human neutrophil oxidative burst
9. Effects of non-steroidal anti-inflammatory drugs on human neutrophil NADPH oxidase in both whole cell and cell-free systems
10. Hydrocortisone inhibits the respiratory burst oxidase from human neutrophils in whole-cell and cell-free systems
11. New concepts in the pathogenesis of bronchial hyperresponsiveness and asthma
12. Role of inflammation in the hyperreactivity of the airways in asthma
13. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol
14. Use of sodium cromoglycate and other anti-allergic drugs in asthma
15. 4
16. Inhibition of calcium ionophore (A23187)-stimulated histamine release from rat peritoneal mast cells by azelastine: Implications for its mode of action
17. Ketotifen in the prophylaxis of bonchial asthma
18. The pharmacological properties of a new, orally active antianaphylactic compound: Ketotifen, a benzocycloheptathiophene
19. Oxatomide inhibits the release of chemical mediators from human lung tissues and from granulocytes
20. Inhibitory effects of oxatomide on several activities of SRS-A and synthetic leukotrienes in guinea-pigs and rats
21. Effect of N-5′ on histamine release from rat peritoneal exudate cells induced by calcium ionophore and ATP
22. Inhibition of anaphylactic chemical mediator release by tranilast
23. Inhibitory effect on the release of mediators from rat peritoneal exudate cells and antagonistic effect against mediators of MY-5116 and other anti-allergic agents
24. Pharmacological studies on newly synthesized anti-allergic agents, 2-methyl-3-piperidino-β-propionaphtone hydrochloride (KZ-111) and 3-isobutyryl-2-isopropylpyrazole-[l , 5-a]pyridine (KC-404)
25. Human neutrophil cytosolic activation factor of the NADPH oxidase: Characterization of activation kinetics
26. Activation of the NADPH oxidase in a cell-free system from human neutrophils stimulated by phorbol myristate acetate
27. Protein measurement with the Folin phenol reagent
28. 2, and ferrocytochrome c and enzymic determination of extinction coefficients of cytochrome c
29. Bronchoconstriction produced in man by leukotrienes C and D
30. 4, increase the release of mucus from human airways in vitro
31. 4 production by the human alveolar macrophage: A potential mechanism for amplifying inflammation in the lung
32. 4, in bronchoalveolar lavage in bronchial asthma and other respiratory diseases
33. Antagonism of histamine and leukotrienes by azelastine in isolated guinea pig ileum
34. Oxatomide, a new orally active drug which inhibits both the release and effects of allergic mediators
35. The effects of the H1 and H2 antihistamines on “allergic” histamine release and its inhibition by histamine
36. Demonstration of inhibition of mediator release from human mast cells by azatadine base: In vivo and in vitro evaluation
37. Effect of cetirizine on mast cell-mediator release and cellular traffic during the cutaneous late-phase reaction
38. Inhibitory effect of oral cetirizine on in vivo antigen-induced histamine and PAF-acether release and eosinophil recruitment in human skin
39. Immunologic and nonimmunologic generation of Superoxide from mast cells and basophils
40. Xanthine oxidase-induced histamine release from isolated rat peritoneal mast cells: Involvement of hydrogen peroxide
41. Properties of hydrogen peroxide-induced histamine release from rat mast cells
42. The role of hydrogen peroxide in basophil histamine release and the effect of selected flavonoids
43. Comparison of the effect of loratadine on the airway and skin responses to histamine, methacholine and allergen in subjects with asthma
44. The inhibitory actions of azelastine hydrochloride on the early and late bronchoconstrictor responses to inhaled allergen in atopic asthma
45. A dose-response study of the bronchodilator action of azelastine in asthma
46. 1antihistaminic drug treatment of asthma